UBS Group’s Cartica Acquisition Corp Class A Ordinary Shares CITE Stock Holding History

UBS Group’s Portfolio CITE Stock Details CITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-191	Closed	-$2.26K	–	11037
2024 Q4	$2.26K	Buy	+191	New	+$2.22K	﹤0.01%	9078
2024 Q3	–	Sell	-2	Closed	-$23	–	10274
2024 Q2	$23	Buy	+2	New	+$22	﹤0.01%	9301
2023 Q1	–	Sell	-402	Closed	-$4.15K	–	10620
2022 Q4	$4.15K	Hold	402	–	–	﹤0.01%	9376
2022 Q3	$4K	Hold	402	–	–	﹤0.01%	9419
2022 Q2	$4K	Sell	402 -351	-47%	-$3.51K	﹤0.01%	9163
2022 Q1	$8K	Buy	+753	New	+$7.5K	﹤0.01%	8719

Other funds holding CITE

MSU

Mizuho Securities USA New York $4.24B AUM 22.54% 1-Year Est. Return

UBS Group's CITE Position: Q1 2025 in Review

UBS Group sold out of Cartica Acquisition Corp Class A Ordinary Shares (CITE) in Q1 2025, closing a stake of 191 shares — an estimated $2.26K sold.

UBS Group first reported a position in CITE in Q1 2022 and held it in 6 quarters. The position peaked at $8K in Q1 2022. 1 fund tracked by Wall St. Rank holds CITE as of Q1 2025.

UBS Group reported no remaining Cartica Acquisition Corp Class A Ordinary Shares position as of Q1 2025 after selling out during the quarter.
UBS Group sold 191 Cartica Acquisition Corp Class A Ordinary Shares shares in Q1 2025, an estimated $2.26K.
UBS Group first reported a position in Cartica Acquisition Corp Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
UBS Group's Cartica Acquisition Corp Class A Ordinary Shares position peaked at $8K in Q1 2022.
1 fund tracked by Wall St. Rank held Cartica Acquisition Corp Class A Ordinary Shares as of Q1 2025.

Based on UBS Group's 13F filing for Q1 2025, filed 13 May 2025.